- active not recruitingPHASE2
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
This study looks at the long-term safety of a medicine called relacorilant for people with Cushing's syndrome. It's for those who have already tried relacorilant in a previous study and who their doctor thinks would benefit from continuing the treatment.
United States · Austria · Canada - recruitingPHASE2
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
This study looks at a new medicine called osilodrostat (LCI699) for children and teenagers aged 2-17 with Cushing's syndrome. Researchers want to see how the medicine works in the body, its effects, and if it's safe. It's for those who have had surgery, are waiting for it, or can't have it right away.
United States · Belgium · Bulgaria